Delivery Order SPE2DB24D9131-SPE2DB25FXRU9
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on July 26, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a direct fulfillment of pharmaceutical supply needs for federal healthcare systems. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $37,000 by the Defense Logistics Agency on August 25, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a Firm Fixed Price delivery order contract from the Defense Logistics Agency (DLA) valued at $74,107.32. The contract, which is not associated with a set-aside designation, covers the delivery of Trikafta, a specialty pharmaceutical medication, to support the medical supply needs of military healthcare facilities. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on August 18, 2025. The delivery order, which is effective through August 19, 2025, calls for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This award was issued without a set-aside designation, allowing the vendor to compete directly in the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on July 28, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The order, which carries an ultimate completion date of July 29, 2025, represents a standard pharmaceutical supply transaction without set-aside designation. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,314.19 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Trikafta 80-40-60mg/59.5mg packets (14-count). This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a continuation of DMS Pharmaceutical Group's role as a critical pharmaceutical supplier to the federal...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRU9Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $18,488.12 from the Defense Logistics Agency (DLA) on September 12, 2025. The delivery order, which is expected to be completed by September 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. The delivery order falls under the company's existing single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November 2026. As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group distributes branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company has maintained a robust portfolio of contract awards with the DLA covering an extensive range of pharmaceutical products, from oncology treatments to specialty medications. This particular delivery order exemplifies the operational efficiency of the IDC vehicle, enabling the DLA to procure critical pharmaceutical supplies on a firm fixed-price basis to support military health facility needs across the global footprint.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 9/12/25 |